Cargando…

Site-specific analysis of the SARS-CoV-2 glycan shield

The emergence of the betacoronavirus, SARS-CoV-2 that causes COVID-19, represents a significant threat to global human health. Vaccine development is focused on the principal target of the humoral immune response, the spike (S) glycoprotein, that mediates cell entry and membrane fusion. SARS-CoV-2 S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Yasunori, Allen, Joel D., Wrapp, Daniel, McLellan, Jason S., Crispin, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239077/ https://www.ncbi.nlm.nih.gov/pubmed/32511336 http://dx.doi.org/10.1101/2020.03.26.010322

Ejemplares similares

Site-specific glycan analysis of the SARS-CoV-2 spike
por: Watanabe, Yasunori, et al.
Publicado: (2020)

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
por: Watanabe, Yasunori, et al.
Publicado: (2020)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2023)

The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2022)

Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
por: Newby, Maddy L., et al.
Publicado: (2023)

Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition
por: Allen, Joel D., et al.
Publicado: (2021)

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)

Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
por: Watanabe, Yasunori, et al.
Publicado: (2018)

Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic
por: Chawla, Himanshi, et al.
Publicado: (2022)

Contemporaneous SARS-CoV-2-Neutralizing Antibodies Mediated by N-glycan Shields
por: Baghaie, Leili, et al.
Publicado: (2023)

Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition
por: Grant, Oliver C., et al.
Publicado: (2020)

A glycan gate controls opening of the SARS-CoV-2 spike protein
por: Sztain, Terra, et al.
Publicado: (2021)

A glycan gate controls opening of the SARS-CoV-2 spike protein
por: Sztain, Terra, et al.
Publicado: (2021)

The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation
por: Wrapp, Daniel, et al.
Publicado: (2019)

Global site-specific analysis of glycoprotein N-glycan processing
por: Cao, Liwei, et al.
Publicado: (2018)

Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
por: Allen, Joel D., et al.
Publicado: (2021)

Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
por: Grant, Oliver C., et al.
Publicado: (2020)

Fine-tuning the spike: role of the nature and topology of the glycan shield in the structure and dynamics of the SARS-CoV-2 S
por: Harbison, Aoife M., et al.
Publicado: (2021)

Prolonged evolution of the human B cell response to SARS-CoV-2 infection
por: Sakharkar, Mrunal, et al.
Publicado: (2021)

Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
por: Huang, Han-Yi, et al.
Publicado: (2022)

The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade
por: Bonomelli, Camille, et al.
Publicado: (2011)

Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples
por: Morley, Gabriella L., et al.
Publicado: (2020)

Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies
por: Amin, Mohammed N., et al.
Publicado: (2013)

Concerted hinge motions in SARS-CoV-2 spike modulated by glycan-glycan and glycan-lipid interactions
por: Kapoor, Karan, et al.
Publicado: (2022)

The impact of non-synonymous mutations on miRNA binding sites within the SARS-CoV-2 NSP3 and NSP4 genes
por: Rad, S. M. Ali Hosseini, et al.
Publicado: (2023)

Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
por: Wrapp, Daniel, et al.
Publicado: (2020)

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
por: Wrapp, Daniel, et al.
Publicado: (2020)

Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures
por: Melero, Roberto, et al.
Publicado: (2020)

Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures
por: Melero, Roberto, et al.
Publicado: (2020)

Suppression of O-Linked Glycosylation of the SARS-CoV-2 Spike by Quaternary Structural Restraints
por: Eldrid, Charles F. S., et al.
Publicado: (2021)

Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting
por: Hosseini Rad SM, Ali, et al.
Publicado: (2020)

A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein
por: Martin, William R., et al.
Publicado: (2020)

Binding of the SARS-CoV-2 spike protein to glycans
por: Hao, Wei, et al.
Publicado: (2021)

The roles of glycans in the SARS-CoV-2 spike protein
por: Casalino, Lorenzo, et al.
Publicado: (2022)

Principles of SARS-CoV-2 glycosylation
por: Chawla, Himanshi, et al.
Publicado: (2022)

Rational Development of Hypervalent Glycan Shield‐Binding Nanoparticles with Broad‐Spectrum Inhibition against Fatal Viruses Including SARS‐CoV‐2 Variants
por: Li, Ying, et al.
Publicado: (2022)

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
por: Ku, Zhiqiang, et al.
Publicado: (2021)

Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions
por: Seabright, Gemma E., et al.
Publicado: (2020)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
por: Yang, Mingjun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sfbm4nvratiald0j26g9unsb4p